fbpx
September 9, 2020

Cardiovascular and Renal Drugs Advisory Committee Charter

Authority The Cardiovascular and Renal Drugs Advisory Committee was established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, 341, 342, 343, 343-1, 344, 345, 346, […]
September 9, 2020

Mezclar medicamentos y suplementos alimenticios puede poner en peligro su salud

English Subscríbase para recibir artículos para el consumidor en español por email. Cuando toma medicamentos recetados o de venta sin receta (OTC, por sus siglas en […]
September 9, 2020

No se deje engañar por estafas del fraude de la salud

Baje esta imagen en alta resolución en Flickr. Cómo detectar una estafa: CURA DE TODO! Para enfermedades no relacionadas CURA MÁGICA! Solo en días REMEDIO ANCESTRAL! […]
September 9, 2020

La FDA insta a ampliar la participación y la diversidad en los ensayos clínicos

English Los ensayos clínicos son estudios de investigación voluntarios que están diseñados para responder a preguntas específicas sobre la seguridad y eficacia de medicamentos, vacunas, dispositivos […]
September 9, 2020

5 Tips for Traveling to the U.S. With Medications

Español You’re returning from a trip overseas and want to bring back over-the-counter drugs from Europe that aren’t available here. Can you? Your mother-in-law is visiting […]
September 9, 2020

Oncologic Drugs Advisory Committee Charter

Authority The Oncologic Drugs Advisory Committee was established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, 341, 342, 343, 343-1, 344, 345, 346, 348, 349, […]
September 8, 2020

Regulatory Education for Industry: Regulated Bioanalysis Workshop: Requirements and Expectations – 06/30/2020

Keynote Address ShaAvhrée Buckman-GarnerDirectorOffice of Translational Sciences (OTS) Bioanalytical Method Validation: History, Process, and Regulatory Perspectives Patrick FaustinoLab ChiefDivision of Product Quality Research (DPQR)Office of Testing […]
September 8, 2020

FDA issues alert about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer 

On September 8, 2020, the Food and Drug Administration alerted health care professionals, oncology clinical investigators, and patients that a clinical trial studying the use of […]
September 8, 2020

FDA approves pralsetinib for lung cancer with RET gene fusions

On September 4, 2020, the Food and Drug Administration granted accelerated approval to pralsetinib (GAVRETOTM, Blueprint Medicines Corporation) for adult patients with metastatic RET fusion-positive non-small […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0